KN
VENTE TOTALE: 206 618 titres (~8 050 092,67 $ US)
- Insiders
- SHAVERS CHERYL L, Niew Jeffrey
- Total bought
- —
- Total sold
- $8,050,093
- Last activity
- 2026-08-17
- Last synced
-
2026-08-23 00:12:53
Insider holdings as a share of total assets aren't available for this company.
Price (1 year)
Live chart from TradingView - pulls its own market data, independent of this site's database. Symbol resolution is best-effort (defaults to NASDAQ) since we don't store the exchange prefix.
Market snapshot
Signal
Neutral signal Scored 2026-09-06
KN presents solid liquidity (85) and an encouraging 2025 financial recovery with conservative leverage, but the moderate catalyst score (45) is significantly weighed down by ~$8M in insider selling that directly…
The first sentence of the analysis written for KN on 2026-09-06 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 41.2% | 40.0% | 43.8% | 47.4% | 39.3% | |
| Ebit Margin | 12.4% | 9.9% | 9.8% | 19.1% | 13.7% | |
| Ebitda Margin | 18.5% | 16.7% | 15.5% | 30.4% | 20.9% | |
| Operating Profit Margin | 13.1% | 10.2% | 10.8% | 19.0% | 13.6% | |
| Pretax Profit Margin | 10.8% | 6.3% | 8.2% | 18.3% | 12.0% | |
| Continuous Operations Profit Margin | 8.6% | 4.2% | 14.4% | 13.9% | 17.3% | |
| Net Profit Margin | 7.5% | -43.3% | 15.8% | -89.8% | 17.3% | |
| Bottom Line Profit Margin | 7.5% | -43.3% | 15.8% | -89.8% | 17.3% | |
| Current Ratio | 2.752 | 1.829 | 2.605 | 3.657 | 2.288 | |
| Quick Ratio | 1.575 | 1.232 | 1.834 | 1.947 | 1.367 | |
| Solvency Ratio | 0.292 | -0.557 | 0.230 | -1.970 | 0.774 | |
| Cash Ratio | 0.512 | 0.658 | 0.530 | 0.486 | 0.415 | |
| Price To Earnings Ratio | 42.020 | -7.409 | 22.387 | -3.501 | 14.325 | |
| Price To Earnings Growth Ratio | -0.353 | 0.017 | -0.191 | 0.009 | 0.003 | |
| Forward Price To Earnings Growth Ratio | -0.353 | 0.017 | -0.191 | 0.009 | 0.003 | |
| Price To Earnings Diluted Ratio | 42.860 | -7.464 | 22.671 | -3.501 | 14.686 | |
| Price To Earnings Diluted Growth Ratio | -0.361 | 0.017 | -0.194 | 0.009 | 0.003 | |
| Price To Book Ratio | 2.370 | 2.344 | 1.574 | 1.516 | 1.477 | |
| Price To Sales Ratio | 3.100 | 3.201 | 3.564 | 3.145 | 2.483 | |
| Price To Free Cash Flow Ratio | 22.450 | 15.208 | 15.431 | 27.781 | 16.144 | |
| Price To Operating Cash Flow Ratio | 16.129 | 13.619 | 13.268 | 17.447 | 11.835 | |
| Debt To Assets Ratio | 0.143 | 0.190 | 0.196 | 0.054 | 0.059 | |
| Debt To Equity Ratio | 0.194 | 0.282 | 0.277 | 0.065 | 0.070 | |
| Debt To Capital Ratio | 0.162 | 0.220 | 0.217 | 0.061 | 0.066 | |
| Long Term Debt To Capital Ratio | 0.144 | 0.151 | 0.178 | 0.043 | 0.046 | |
| Financial Leverage Ratio | 1.355 | 1.479 | 1.415 | 1.192 | 1.186 | |
| Working Capital Turnover Ratio | 3.397 | 2.586 | 1.732 | 2.006 | 5.161 | |
| Operating Cash Flow Ratio | 1.076 | 0.658 | 0.745 | 0.871 | 1.096 | |
| Operating Cash Flow Sales Ratio | 0.192 | 0.235 | 0.269 | 0.180 | 0.210 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.718 | 0.895 | 0.860 | 0.628 | 0.733 | |
| Debt Service Coverage Ratio | 7.201 | 0.915 | 1.820 | 28.884 | 15.771 | |
| Interest Coverage Ratio | 8.355 | 2.821 | 6.676 | 21.116 | 8.208 | |
| Short Term Operating Cash Flow Coverage Ratio | 27.805 | 1.899 | 2.605 | 0.000 | 0.000 | |
| Operating Cash Flow Coverage Ratio | 0.758 | 0.611 | 0.428 | 1.338 | 1.778 | |
| Capital Expenditure Coverage Ratio | 3.551 | 9.566 | 7.134 | 2.688 | 3.747 | |
| Dividend Paid And Capex Coverage Ratio | 2.977 | 9.566 | 7.134 | 2.688 | 3.747 | |
| Dividend Payout Ratio | 0.140 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | 17.653 | 20.072 | 25.775 | 10.461 | 12.059 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 41.2% | ▲1.2% | ▼-1.1% |
| Ebit Margin | 12.4% | ▲2.5% | ▼-0.6% |
| Ebitda Margin | 18.5% | ▲1.8% | ▼-1.9% |
| Operating Profit Margin | 13.1% | ▲2.9% | ▼-0.2% |
| Pretax Profit Margin | 10.8% | ▲4.5% | ▼-0.3% |
| Continuous Operations Profit Margin | 8.6% | ▲4.3% | ▼-3.1% |
| Net Profit Margin | 7.4% | ▲50.7% | ▲25.9% |
| Bottom Line Profit Margin | 7.4% | ▲50.7% | ▲25.9% |
| Current Ratio | 2.752 | ▲0.923 | ▲0.126 |
| Quick Ratio | 1.575 | ▲0.343 | ▼-0.016 |
| Solvency Ratio | 0.292 | ▲0.850 | ▲0.539 |
| Cash Ratio | 0.512 | ▼-0.147 | ▼-0.009 |
| Price To Earnings Ratio | 42.020 | ▲49.428 | ▲28.455 |
| Price To Earnings Growth Ratio | -0.353 | ▼-0.370 | ▼-0.250 |
| Forward Price To Earnings Growth Ratio | -0.353 | ▼-0.370 | ▼-0.250 |
| Price To Earnings Diluted Ratio | 42.860 | ▲50.324 | ▲29.010 |
| Price To Earnings Diluted Growth Ratio | -0.361 | ▼-0.378 | ▼-0.256 |
| Price To Book Ratio | 2.370 | ▲0.026 | ▲0.514 |
| Price To Sales Ratio | 3.100 | ▼-0.101 | ▲0.001 |
| Price To Free Cash Flow Ratio | 22.451 | ▲7.242 | ▲3.047 |
| Price To Operating Cash Flow Ratio | 16.129 | ▲2.510 | ▲1.669 |
| Debt To Assets Ratio | 0.143 | ▼-0.048 | ▲0.014 |
| Debt To Equity Ratio | 0.194 | ▼-0.088 | ▲0.016 |
| Debt To Capital Ratio | 0.162 | ▼-0.058 | ▲0.017 |
| Long Term Debt To Capital Ratio | 0.144 | ▼-0.007 | ▲0.031 |
| Financial Leverage Ratio | 1.355 | ▼-0.124 | ▲0.029 |
| Working Capital Turnover Ratio | 3.397 | ▲0.810 | ▲0.420 |
| Operating Cash Flow Ratio | 1.077 | ▲0.418 | ▲0.187 |
| Operating Cash Flow Sales Ratio | 0.192 | ▼-0.043 | ▼-0.025 |
| Free Cash Flow Operating Cash Flow Ratio | 0.718 | ▼-0.177 | ▼-0.049 |
| Debt Service Coverage Ratio | 7.202 | ▲6.286 | ▼-3.717 |
| Interest Coverage Ratio | 8.355 | ▲5.534 | ▼-1.080 |
| Short Term Operating Cash Flow Coverage Ratio | 27.805 | ▲25.906 | ▲21.343 |
| Operating Cash Flow Coverage Ratio | 0.758 | ▲0.148 | ▼-0.224 |
| Capital Expenditure Coverage Ratio | 3.551 | ▼-6.015 | ▼-1.786 |
| Dividend Paid And Capex Coverage Ratio | 2.977 | ▼-6.590 | ▼-2.246 |
| Dividend Payout Ratio | 0.140 | ▲0.140 | ▲0.112 |
| Enterprise Value Multiple | 17.653 | ▼-2.419 | ▲0.449 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $1.84B | $1.77B | $1.63B | $1.51B | $2.16B | |
| Enterprise value | $1.93B | $1.85B | $1.83B | $1.52B | $2.19B | |
| EV / Sales | 3.26x | 3.35x | 4.00x | 3.18x | 2.52x | |
| EV / Op. cash flow | 16.97x | 14.26x | 14.89x | 17.64x | 12.02x | |
| EV / Free cash flow | 23.62x | 15.92x | 17.32x | 28.08x | 16.39x | |
| EV / EBITDA | 17.65x | 20.07x | 25.77x | 10.46x | 12.06x | |
| Net debt / EBITDA | 0.88x | 0.90x | 2.81x | 0.11x | 0.18x | |
| Current ratio | 2.75x | 1.83x | 2.60x | 3.66x | 2.29x | |
| Income quality | 2.58x | 5.56x | 1.87x | -0.20x | 1.21x | |
| Graham number | $10 | — | $14 | — | $24 | |
| Graham net-net | -$1 | -$1 | -$2 | $0 | -$0 | |
| Tax burden | 69.1% | -690.2% | 194.1% | -490.4% | 143.8% | |
| Interest burden | 87.3% | 63.3% | 83.4% | 95.7% | 87.9% | |
| Working capital | $185.5M | $163.8M | $264.2M | $263.3M | $214.1M | |
| Invested capital | $756.2M | $729.7M | $866.4M | $993.8M | $1.47B | |
| Return on assets | 4.2% | -21.4% | 4.9% | -36.3% | 8.7% | |
| Operating ROA | 7.2% | 4.4% | 3.7% | 6.2% | 7.0% | |
| Return on tangible assets | 6.9% | -34.7% | 7.1% | -68.5% | 21.7% | |
| Return on equity | 5.7% | -31.7% | 7.0% | -43.3% | 10.3% | |
| Return on invested capital | 6.5% | 3.8% | 3.7% | 6.3% | 7.5% | |
| Return on capital employed | 8.2% | 6.2% | 3.8% | 8.4% | 7.6% | |
| Earnings yield | 2.4% | -13.5% | 4.4% | -28.6% | 7.0% | |
| Free cash flow yield | 4.5% | 6.6% | 6.5% | 3.6% | 6.2% | |
| Capex / Op. cash flow | 28.2% | 10.5% | 14.0% | 37.2% | 26.7% | |
| Capex / Depreciation | 88.4% | 36.2% | 65.6% | 59.6% | 77.8% | |
| Capex / Sales | 5.4% | 2.5% | 3.8% | 6.7% | 5.6% | |
| SG&A / Sales | 24.1% | 23.0% | 26.1% | 24.4% | 15.0% | |
| R&D / Sales | 6.8% | 6.7% | 6.9% | 17.1% | 10.7% | |
| Stock comp / Sales | 4.8% | 0.0% | 0.0% | 6.0% | 0.0% | |
| Intangibles / Total assets | 39.1% | 38.2% | 30.5% | 47.0% | 60.0% | |
| Days sales outstanding | 63d | 69d | 72d | 103d | 62d | |
| Days payables outstanding | 45d | 64d | 51d | 60d | 63d | |
| Operating cycle | 194d | 199d | 253d | 348d | 168d | |
| Cash conversion cycle | 149d | 135d | 202d | 288d | 105d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▲+3.8%EV / Sales ▼-2.7%EV / EBITDA ▼-12.1%EV / Op. cash flow ▲+2.716Earnings yield ▲+0.159
Profitability
Return on equity ▲+0.374Return on assets ▲+0.256Return on invested capital ▲+0.027Return on capital employed ▲+0.021Operating ROA ▲+0.028Income quality ▼-2.981Tax burden ▲+7.593
Efficiency
Days sales outstanding ▼-5.988Days payables outstanding ▼-19.351Operating cycle ▼-5.175Cash conversion cycle ▲+14.176Capex / Sales ▲+0.030R&D / Sales ▲+0.001
Balance-sheet strength
Current ratio ▲+0.923Net debt / EBITDA ▼-0.020Working capital ▲+21700000.000Invested capital ▲+26500000.000Intangibles / Total assets ▲+0.009
Change over 5 years
Valuation
Market cap ▼-14.7%EV / Sales ▲+29.4%EV / EBITDA ▲+46.4%EV / Op. cash flow ▲+4.953Earnings yield ▼-0.046Graham number ▼-13.840
Profitability
Return on equity ▼-0.046Return on assets ▼-0.045Return on invested capital ▼-0.010Return on capital employed ▲+0.007Operating ROA ▲+0.002Income quality ▲+1.367Tax burden ▼-0.747
Efficiency
Days sales outstanding ▲+1.614Days payables outstanding ▼-18.100Operating cycle ▲+25.921Cash conversion cycle ▲+44.021Capex / Sales ▼-0.002R&D / Sales ▼-0.039
Balance-sheet strength
Current ratio ▲+0.463Net debt / EBITDA ▲+0.692Working capital ▼-28600000.000Invested capital ▼-714699999.000Intangibles / Total assets ▼-0.208
Employee count
Peer market caps
Congressional trades
No congressional trade data synced.
Recent news
- 2026-08-20 Knowles Corporation $KN Shares Sold by Bank of America Corp DE Bank of America Corp DE decreased its stake in shares of Knowles Corporation (NYSE: KN) by 9.9% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 755,323 shares of the communications equipment provider''s stock after selling 83,419 shares during
- 2026-08-14 Knowles (KN) Is Up 6.81% in One Week: What You Should Know Does Knowles (KN) have what it takes to be a top stock pick for momentum investors? Let''s find out.
- 2026-08-12 Elucent Medical Selects Knowles Corporation to Manufacture Advanced Surgical Guidance Device Elucent chooses Knowles for micro molding capabilities, design-for-manufacturability expertise, and vertically integrated assembly to accelerate production of their critical surgical guidance device. ITASCA, Ill.
- 2026-07-31 Conestoga SMid Cap Composite Q2 2026 Portfolio Review West Pharmaceuticals stock moved higher following another quarter of broad-based growth, driven by continued demand for high-value biologics packaging and proprietary delivery components. Tyler Technologies underperformed during the quarter despite delivering solid financial results that met management''s guidance. We were attracted to Knowles'' accelerating organic growth, expanding margins, and exposure to several attractive long-term secular trends.
- 2026-07-31 Bank of New York Mellon Corp Sells 32,082 Shares of Knowles Corporation $KN Bank of New York Mellon Corp reduced its stake in shares of Knowles Corporation (NYSE: KN) by 5.6% during the undefined quarter, according to its most recent 13F filing with the SEC. The firm owned 543,697 shares of the communications equipment provider''s stock after selling 32,082 shares during the period. Bank of New
- 2026-07-29 All You Need to Know About Knowles (KN) Rating Upgrade to Strong Buy Knowles (KN) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company''s earnings prospects. This might drive the stock higher in the near term.
- 2026-07-23 Knowles Q2 Earnings Call Highlights Knowles NYSE: KN reported second-quarter 2026 results above its guidance range, with management pointing to broad-based demand across its Precision Devices business and steady performance in MedTech & Specialty Audio.
- 2026-07-23 Knowles Corporation (KN) Q2 2026 Earnings Call Transcript Knowles Corporation (KN) Q2 2026 Earnings Call Transcript
- 2026-07-23 Knowles (KN) Beats Q2 Earnings and Revenue Estimates Knowles (KN) came out with quarterly earnings of $0.33 per share, beating the Zacks Consensus Estimate of $0.3 per share. This compares to earnings of $0.24 per share a year ago.
- 2026-07-23 Knowles Reports Q2 2026 Financial Results and Provides Outlook for Q3 2026 ITASCA, Ill.--(BUSINESS WIRE)--Knowles Corporation (NYSE: KN), a leading manufacturer of specialty electronic components, including high performance capacitors, radio frequency ("RF") filters, advanced medtech microphones, and balanced armature speakers, today announced results for the quarter ended June 30, 2026. “We delivered second quarter revenues exceeding the high end of our guided range. Non-GAAP diluted EPS was above the high end of our guided range and cash from operations was within t.